Hao Liu, Ph.D

Novel Synthesis of Perfluoroalkylated Indolizinylphosphonates via a DIPEA-promoted One-pot Process. H. Liu, Dong He, Zhenhua Sun, Weimin He, Jing Han, Jie Chen, Hongmei Deng, Min Shao, Hui Zhang, Weiguo Cao. Tetrahedron 74, 135-141, (2018)
A bioactive ligandconjugated iridium(III) metal-based complex as a Keap1–Nrf2 protein-protein interaction inhibitor against acetaminophen-induced acute liver injury. G. Li, H. Liu (co-first author), T.-S. Kang, D.-L. Ma, C.-H. Leung. Redox Biology 48, 102129, (2021)
Base-promoted [3+2] cycloaddition/aromatization cascade reaction under air: An approach to access perfluoroalkylated pyrrolo[2,1-a]isoquinolines. Wei Zhou, H. Liu (co-first author), Yongyi Guo, Hui Zhang, Weiguo Cao. Journal of Fluorine Chemistry 222-223, 51-58, (2019).
A robust photoluminescence screening assay identifies uracil-DNA glycosylase inhibitors against prostate cancer.G. Li, S.-A. Henry, H. Liu (co-first author), T.-S. Kang, S.-C. Nao, Y.-C. Zhao, C. Wu, J.- W. Jin, J.-T. Zhang, C.-H. Leung, P. W.-H. Chan, D.-L. Ma. Chem. Sci., 11, 1750, (2020)
Mimicking strategy for protein-protein interaction inhibitor discovery by virtual screening. K.-J. Wu, P.-M. Lei, H. Liu, C. Wu, C.-H. Leung, D.-L. Ma. Molecules 24, 4428, (2019).

2011-2015: Bacholar at Department of Applied Chemistry, College of Applied Chemistry, Shenyang University of Science and Technology, P. R. China
2015-2018: Master at Department of Chemistry, College of Sciences, Shanghai University, Shanghai, P. R. China
2019-2023: Ph.D. at Department of Chemistry, College of Sciences, Hong Kong Baptist University, Hong Kong, China

2018-2019: Research Assistant at Department of Chemistry, College of Sciences, Hong Kong Baptist University, Hong Kong, P. R. China
2023-2024: Postdoctoral Fellow, BESE Division, KAUST, Saudi Arabia.
2024-Present: Postdoctoral Fellow, PSE Division, KAUST, Saudi Arabia.

Controlled/living polymerizations Multiple H-bonding Polymer-Oligopeptide Conjugates